SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
2017
The therapeutic response of acute myeloid leukemia to the nucleoside analog Ara-C is controlled by SAMHD1, an enzyme that hydrolyzes the active metabolite Ara-CTP.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
39
References
76
Citations
NaN
KQI